Abnormalities of the Immune System in Cancer Patients Question Title * 1. I attended this web program as a: (select one). Patient Caregiver Family Member Friend/Concerned Individual Healthcare Professional Community Member LLS Staff LLS Volunteer Other (please specify) Question Title * 2. What is your race or ethnicity? Asian Black or African American Hispanic or Latino American Indian or Alaskan Native Native Hawaiian or other Pacific Islander White Prefer not to disclose Question Title * 3. Are you Hispanic/Latino/a/x? Yes No Question Title * 4. What is your date of birth? (MM/DD/YYYY) Date Question Title * 5. Do you describe yourself as a man, a woman, or in some other way? A Man A Woman Prefer not to answer In some other way (with open text field) Question Title * 6. In what ZIP/Postal code is your home located? Question Title * 7. Have you or the patient been diagnosed with a blood cancer? Yes No N/A If no, please tell us the type of cancer with which you/patient were diagnosed: Question Title * 8. If yes, when were you/patient diagnosed? (MM/DD/YYYY): Question Title * 9. If yes, please tell us what type of blood cancer (check all that apply): Non-Hodgkin lymphoma (NHL) Mantle cell lymphoma (MCL) Hodgkin lymphoma (HL) Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Myelodysplastic syndromes Myeloproliferative neoplasms (MPN) (polycythemia vera, essential thrombocythemia, myelofibrosis) Multiple myeloma Other (please specify) Question Title * 10. Are you or the patient currently being treated? Yes No Question Title * 11. What treatments have you or the patient had? (check all that apply): Combination drug therapy (chemotherapy) Single Drug Therapy Allogeneic stem cell transplant (donor) Autologous stem cell transplant CAR T- cell Therapy Radiation therapy Immunotherapy Blood transfusions Watch & Wait N/A Other (please specify) Question Title * 12. Are you presently in or have you ever participated in a clinical trial? Yes No N/A Question Title * 13. Is there a COVID-19 treatment/prophylaxis that you would like to find out more about? Question Title * 14. Please check true or false. As a result of this program True False I learned about infectious complications in patients with blood cancers with a focus on abnormalities in the immune system. I learned about infectious complications in patients with blood cancers with a focus on abnormalities in the immune system. True I learned about infectious complications in patients with blood cancers with a focus on abnormalities in the immune system. False I learned about the current standard of practice to decrease infectious complications in patients with blood cancers. I learned about the current standard of practice to decrease infectious complications in patients with blood cancers. True I learned about the current standard of practice to decrease infectious complications in patients with blood cancers. False I learned about special considerations for blood cancer patients regarding the COVID-19 pandemic. I learned about special considerations for blood cancer patients regarding the COVID-19 pandemic. True I learned about special considerations for blood cancer patients regarding the COVID-19 pandemic. False Question Title * 15. Which form(s) of cancer education do you most prefer? Webcasts (live or pre-recorded) Short videos Podcasts Booklets Other (please specify) Question Title * 16. Please describe any information you expected to get from this program but did not receive. Question Title * 17. Please give us any additional feedback about this program. Done